Potential partners are invited to explore
collaboration opportunities with VUNO Med®-DeepBrain®, a highly
accurate AI solution for research and clinical settings.
MARLBOROUGH, Mass., June 17,
2024 /PRNewswire/ -- VUNO—acclaimed as a pioneer in AI-based
medical solutions—announced 3 upcoming poster presentations
showcasing their latest brain analysis research at the Alzheimer's
Association International Conference (AAIC). Discover collaboration
opportunities for improved monitoring and diagnosis of patients
with Alzheimer's Dementia and other neurological diseases. See
poster presentations and live demos at AAIC booth exhibit #1411
from July
28th to August
1st in Philadelphia, PA.
The poster presentations will feature VUNO
Med®-DeepBrain®—FDA-cleared in October
2023, a highly accurate, fast atrophy and WMH measurement AI
solution—within the following topics:
- Quantitative Analysis of Choroid
Plexus Enlargement in Alzheimer's Dementia: A Study of Automated
Volumetric Technique
- Automated Brain Volumetry Analysis for
Differential Diagnosis of Frontotemporal Dementia
Subtypes
- Comparison of Intracranial Volume
Adjustment Methods to Evaluate Brain Atrophy Severity in AD
Continuum
VUNO's researchers and in-house
radiologist will present research
findings and address audience questions.
"We aim to reduce neurodegenerative professionals' workloads
while providing advanced insights to support their practice goals,"
said Yeha Lee, CEO of VUNO. "As part of the commercial U.S. launch
of VUNO Med®-DeepBrain® in 2024, we are collaborating with
leading medical providers, researchers and institutions to pilot our
solution and to provide valuable, real-world feedback."
Neurologists, dementia professionals and researchers attending
AAIC can book a free demo to learn
more about VUNO Med®-DeepBrain® in advance of the show or stop by
booth 1411 during July 28-August 1.
ABOUT VUNO
Headquartered in South Korea with their USA Corporate office located in Marlborough, MA, VUNO is a leading AI medical
software company that develops deep learning-based AI medical
solutions in medical imaging, biosignal, and digital
pathology–optimizing in-clinic and telehealth patient care with
their portfolio of deep learning-based tools.
VUNO innovates internationally recognized solutions with 100+
patents and 100+ publications. VUNO Med®-DeepBrain® is an atrophy
and WMH measurement AI solution that boasts high accuracy and speed
of analysis (1 minute).
For more information, visit
VUNO.us.
ABOUT AAIC
The Alzheimer's Association International
Conference (AAIC) is the largest international meeting
dedicated to advancing dementia science and clinical practice.
Media Contact: us@vuno.co
View original
content:https://www.prnewswire.com/news-releases/vuno-presents-cutting-edge-ai-brain-technology-at-aaic---analyzing-mri-scans-in-1-minute-to-support-diagnosis-of-alzheimers-disease-302171459.html
SOURCE VUNO Inc.